• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow reports fourth quarter 2025 results

    1/29/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials
    Get the next $DOW alert in real time by email

    MIDLAND, Mich., Jan. 29, 2026 /PRNewswire/ -- Dow (NYSE:DOW):

    Dow, Inc. (PRNewsfoto/The Dow Chemical Company)

    FINANCIAL HIGHLIGHTS

    • Net sales were $9.5 billion, down 9% year-over-year, reflecting declines in all operating segments. Sequentially, net sales were down 5%, led by local price and volume declines from normal seasonality.
    • Volume decreased 2% year-over-year, led by declines in Packaging & Specialty Plastics, driven by lower merchant olefins sales in Europe, the Middle East, Africa and India (EMEAI) following the idling of a cracker in the region earlier in the year. Sequentially, volume decreased 2%, led by normal seasonality across building & construction.
    • Local price was down 8% versus the year-ago period and down 3% sequentially.
    • GAAP net loss was $1.5 billion. Op. EBIT1 was $33 million, down $421 million year-over-year. This was primarily driven by price declines and lower operating rates, which were partly offset by tailwinds from the Company's cost reduction program. Sequentially, Op. EBIT decreased $147 million, driven by margin compression and seasonally lower demand, partly offset by lower fixed costs.
    • GAAP loss per share was $2.15; operating earnings per share (EPS)1 was a loss of $0.34, compared to $0.00 in the year-ago period and a loss of $0.19 in the prior quarter. Op. EPS excludes significant items totaling $1.81 per share, led by impairment charges associated with the Polyurethanes & Construction Chemicals business and non-cash pension settlement charges.
    • Cash provided by operating activities – continuing operations was $298 million, down $513 million year-over-year, primarily driven by lower earnings. Sequentially, it was down $832 million, primarily driven by advance payments received for low-carbon solutions and other long-term supply agreements in the prior quarter.
    • Returns to shareholders totaled $251 million of dividends in the quarter.
    • The Company delivered full year net sales of $40.0 billion in 2025. GAAP net loss was $2.4 billion, down from income of $1.2 billion in 2024. Operating EBIT was $0.4 billion, down from $2.6 billion last year. Cash provided by operating activities – continuing operations was $1.1 billion compared to $2.9 billion in 2024. The Company delivered returns to shareholders of $1.5 billion in dividends.

    SUMMARY FINANCIAL RESULTS 



    Three Months Ended Dec 31

    Three Months Ended Sep 30

    In millions, except per share amounts

    4Q25

    4Q24

    vs. SQLY

    [B / (W)]

    3Q25

    vs. PQ

    [B / (W)]

    Net Sales

    $9,460

    $10,405

    $(945)

    $9,973

    $(513)

    GAAP Income (Loss) Net of Tax

    $(1,477)

    $(35)

    $(1,442)

    $124

    $(1,601)

    Operating EBIT¹

    $33

    $454

    $(421)

    $180

    $(147)

    Operating EBITDA¹

    $741

    $1,205

    $(464)

    $868

    $(127)

    GAAP Earnings (Loss) Per Share

    $(2.15)

    $(0.08)

    $(2.07)

    $0.08

    $(2.23)

    Operating Earnings Per Share¹

    $(0.34)

    $0.00

    $(0.34)

    $(0.19)

    $(0.15)

    Cash Provided by (Used for) Operating Activities – Cont. Ops

    $298

    $811

    ($513)

    $1,130

    ($832)















    1.

    Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin and Op. EBITDA, Free Cash Flow and Cash Flow Conversion are non-GAAP measures. See page 6 for further discussion.

    ®TM Trademark of The Dow Chemical Company or an affiliated company of Dow

    CEO QUOTE

    "Dow's self-help measures continue to gain traction and were evident in our fourth quarter results," said Jim Fitterling, Dow chair and CEO. "In 2025, we achieved well over half of our more than $6.5 billion in near-term cash and cost support actions, including the accelerated delivery of more than $400 million in cost savings from our $1 billion program. As we move forward, Transform to Outperform represents a comprehensive and radical simplification of our operating model. It aims to deliver step-change productivity across every business and function and growth with our customers. We expect these efforts to provide at least $2 billion in additional near-term earnings while helping Dow set new competitive standards and improve shareholder returns."

    SEGMENT HIGHLIGHTS

    Packaging & Specialty Plastics



    Three Months Ended Dec 31

    Three Months Ended Sep 30

    In millions

    4Q25

    4Q24

    vs. SQLY

    [B / (W)]

    3Q25

    vs. PQ

    [B / (W)]

    Net Sales

    $4,744

    $5,315

    $(571)

    $4,891

    $(147)

    Operating EBIT

    $215

    $447

    $(232)

    $199

    $16

    Equity Earnings (Losses)

    $(5)

    $(15)

    $10

    $(6)

    $1

    Packaging & Specialty Plastics segment net sales in the quarter were $4.7 billion, down 11% versus the year-ago period1. Local price decreased 9% year-over-year, primarily driven by lower downstream polymer prices. Currency increased net sales by 1%. Volume decreased 2% year-over-year, driven by lower merchant olefins sales in EMEAI following the idling of one of our crackers in the region earlier in the year. On a sequential basis, net sales declined, primarily driven by lower prices for downstream polymers, which were partly offset by higher licensing revenue.

    Equity losses for the segment were $5 million, an improvement of $10 million compared to the prior year, primarily driven by lower fixed costs at Sadara. Sequentially, equity earnings were flat as improvements at Sadara following an unplanned outage last quarter were offset by lower earnings at the Thai joint ventures.

    Op. EBIT was $215 million, a decrease of $232 million compared to the year-ago period, driven by lower integrated margins and operating rates, partly offset by lower fixed costs. Sequentially, Op. EBIT increased by $16 million, driven by lower fixed costs, partly offset by margin compression.

    Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period, driven by lower downstream polymer prices and lower demand in photovoltaics, partly offset by higher demand for wire & cable applications. Sequentially, net sales decreased as lower downstream polymer prices, led by EMEAI, were partly offset by higher licensing revenue and volume gains in polyethylene.

    Hydrocarbons & Energy business reported a net sales decrease both year-over-year and sequentially, driven by lower merchant olefins sales, partly offset by higher energy sales.  

    1.

    Includes a 1% unfavorable impact from the sale of the flexible packaging laminating adhesives business in the fourth quarter of 2024 which is presented as "Portfolio & Other" in the Sales Variances by Segment and Geographic Region table on page 10.

    Industrial Intermediates & Infrastructure



    Three Months Ended Dec 31

    Three Months Ended Sep 30

    In millions

    4Q25

    4Q24

    vs. SQLY

    [B / (W)]

    3Q25

    vs. PQ

    [B / (W)]

    Net Sales

    $2,688

    $2,948

    $(260)

    $2,834

    $(146)

    Operating EBIT

    $(201)

    $84

    $(285)

    $(47)

    $(154)

    Equity Earnings (Losses)

    $(117)

    $(39)

    $(78)

    $(68)

    $(49)

    Industrial Intermediates & Infrastructure segment net sales were $2.7 billion, down 9% versus the year-ago period. Local price declined 9% year-over-year, reflecting declines in both businesses. Currency increased net sales by 1%. Volume decreased 1% year-over-year, primarily driven by lower volumes in Polyurethanes & Construction Chemicals. On a sequential basis, net sales decreased 5% as local price declines and seasonally lower volumes in building & construction were partly offset by seasonal increases in deicing fluid demand. 

    Equity losses for the segment were $117 million, compared to equity losses of $39 million in the year-ago period, driven by lower integrated margins for MEG at the Kuwait joint ventures. Equity losses in the prior quarter were $68 million. Sequentially, the earnings decline was primarily driven by lower MEG margins at the Kuwait joint ventures.

    Op. EBIT decreased $285 million versus the year-ago period, driven by lower integrated margins, partly offset by tailwinds from the Company's cost reduction actions. On a sequential basis, Op. EBIT decreased by $154 million, driven by lower integrated margins and operating rates in both businesses.

    Polyurethanes & Construction Chemicals business reported a decrease in net sales compared to the year-ago period, primarily driven by local price, along with lower volumes in all regions except the U.S. & Canada. Sequentially, net sales decreased, driven by seasonally lower demand for building & construction applications.

    Industrial Solutions business reported a decrease in net sales compared to the year-ago period, primarily driven by lower local prices, while higher demand for deicing fluids was offset by lower ethylene oxide project-related catalyst sales. Sequentially, net sales decreased, as lower local prices were partly offset by seasonally higher demand for deicing fluids.

    Performance Materials & Coatings



    Three Months Ended Dec 31

    Three Months Ended Sep 30

    In millions

    4Q25

    4Q24

    vs. SQLY

    [B / (W)]

    3Q25

    vs. PQ

    [B / (W)]

    Net Sales

    $1,852

    $1,965

    $(113)

    $2,082

    $(230)

    Operating EBIT

    $25

    $(9)

    $34

    $80

    $(55)

    Equity Earnings (Losses)

    $3

    $2

    $1

    $1

    $2

    Performance Materials & Coatings segment net sales in the quarter were $1.9 billion, down 6% versus the year-ago period. Local price decreased 4% year-over-year, driven by declines in both businesses. Currency was flat. Volume was down 2% year-over-year, driven by lower volumes in Coatings & Performance Monomers while volumes in Consumer Solutions were flat. On a sequential basis, net sales were down 11%, driven by seasonally lower demand in both businesses.  

    Op. EBIT increased $34 million versus the year-ago period, primarily driven by lower fixed costs. Sequentially, Op. EBIT decreased $55 million, driven by seasonally lower demand and higher planned maintenance activity.

    Consumer Solutions business reported a decrease in net sales versus the year-ago period, driven by lower upstream siloxanes prices and lower demand in building & construction end markets, partly offset by higher demand for electronics and mobility applications. Sequentially, net sales decreased, primarily driven by seasonally lower demand.

    Coatings & Performance Monomers business reported a decrease in net sales compared to the year-ago period, driven by lower prices, led by declines in acrylic monomers, as well as lower supply availability from a planned turnaround at our Deer Park, Texas methacrylates facility. Sequentially, net sales decreased, primarily driven by seasonally lower demand for architectural coatings and lower supply availability.

    OUTLOOK

    "Team Dow remains focused on delivering near-term cost savings, navigating an unprecedented industry downturn and our long-standing cultural values of safety and reliability," said Fitterling. "At the same time – by reducing complexity, adopting the best available technologies and streamlining our end-to-end processes – Transform to Outperform is expected to provide step-change productivity gains while enabling consistent growth. We will make breakthrough improvements across our company to fundamentally simplify Dow's operating model. Doing so will position us well to work more efficiently, better serve our customers and deliver improved shareholder returns."

    Conference Call

    Dow will host a live webcast of its quarterly earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

    About Dow

    Dow (NYSE:DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employ approximately 34,600 people. Dow delivered sales of approximately $40 billion in 2025. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us at www.dow.com.

     

    Cautionary Statement about Forward-Looking Statements

    Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

    Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow's products and services and ability to compete in such markets; Dow's ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow's information technology networks and systems, including the impact of cyberattacks; risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow's business.

    Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and the Company's subsequent reports filed with the U.S. Securities and Exchange Commission. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

    ®TM Trademark of The Dow Chemical Company or an affiliated company of Dow                 

                    

    Non-GAAP Financial Measures

    This earnings release includes information that does not conform to GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's GAAP disclosures and should not be viewed as alternatives to GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period.

    Operating Earnings Per Share is defined as "Earnings (loss) per common share - diluted" excluding the after-tax impact of significant items.

    Operating EBIT is defined as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items.

    Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.

    Operating EBITDA is defined as earnings (i.e., "Income (loss) before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

    Free Cash Flow is defined as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

    Cash Flow Conversion is defined as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

    Operating Return on Invested Capital ("ROC") is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

     

    Dow Inc. and Subsidiaries

    Consolidated Statements of Income



    In millions, except per share amounts (Unaudited)

    Three Months Ended

    Twelve Months Ended

    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Net sales

    $    9,460

    $   10,405

    $   39,968

    $   42,964

    Cost of sales

    8,912

    9,470

    37,435

    38,358

    Research and development expenses

    173

    202

    752

    810

    Selling, general and administrative expenses

    339

    353

    1,392

    1,581

    Amortization of intangibles

    46

    76

    231

    310

    Restructuring, goodwill impairment and asset related charges - net

    1,034

    34

    1,856

    103

    Equity in losses of nonconsolidated affiliates

    (118)

    (51)

    (240)

    (6)

    Sundry income (expense) - net

    (205)

    159

    140

    415

    Interest income

    38

    57

    152

    200

    Interest expense and amortization of debt discount

    219

    216

    865

    811

    Income (loss) before income taxes

    (1,548)

    219

    (2,511)

    1,600

    Provision (credit) for income taxes

    (71)

    254

    (67)

    399

    Net income (loss)

    (1,477)

    (35)

    (2,444)

    1,201

    Net income attributable to noncontrolling interests

    66

    18

    179

    85

    Net income (loss) available for Dow Inc. common stockholders

    $   (1,543)

    $        (53)

    $   (2,623)

    $    1,116



    —

    —

    —

    —

    Per common share data:









    Earnings (loss) per common share - basic

    $     (2.15)

    $     (0.08)

    $     (3.70)

    $      1.57

    Earnings (loss) per common share - diluted

    $     (2.15)

    $     (0.08)

    $     (3.70)

    $      1.57











    Weighted-average common shares outstanding - basic

    718.2

    704.7

    711.6

    703.8

    Weighted-average common shares outstanding - diluted

    718.2

    704.7

    711.6

    705.1

     

    Dow Inc. and Subsidiaries

    Consolidated Balance Sheets



    In millions, except share amounts (Unaudited)

    Dec 31,

    2025

    Dec 31,

    2024

    Assets





    Current Assets





    Cash and cash equivalents

    $         3,816

    $         2,189

    Accounts and notes receivable:





    Trade (net of allowance for doubtful receivables - 2025: $59; 2024: $95)

    4,762

    4,756

    Other

    1,876

    2,108

    Inventories

    6,595

    6,544

    Other current assets

    1,013

    993

    Total current assets (variable interest entities restricted - 2025: $228; 2024: $55)

    18,062

    16,590

    Investments





    Investment in nonconsolidated affiliates

    1,264

    1,266

    Other investments (investments carried at fair value - 2025: $2,212; 2024: $2,047)

    3,017

    3,033

    Noncurrent receivables

    309

    380

    Total investments

    4,590

    4,679

    Property





    Property

    65,863

    62,121

    Less: Accumulated depreciation

    43,613

    40,117

    Net property (variable interest entities restricted - 2025: $2,385; 2024: $122)

    22,250

    22,004

    Other Assets





    Goodwill

    7,978

    8,565

    Other intangible assets (net of accumulated amortization - 2025: $5,727; 2024: $5,394)

    1,486

    1,721

    Operating lease right-of-use assets

    1,356

    1,268

    Deferred income tax assets

    1,511

    1,257

    Deferred charges and other assets

    1,305

    1,228

    Total other assets (variable interest entities restricted - 2025: $226; 2024: $15)

    13,636

    14,039

    Total Assets

    $       58,538

    $       57,312

    Liabilities and Equity





    Current Liabilities





    Notes payable

    $             90

    $           135

    Long-term debt due within one year

    222

    497

    Accounts payable:





    Trade

    4,151

    4,847

    Other

    1,394

    1,694

    Operating lease liabilities - current

    340

    318

    Income taxes payable

    337

    276

    Accrued and other current liabilities

    2,649

    2,521

    Total current liabilities (variable interest entities restricted - 2025: $438; 2024: $24)

    9,183

    10,288

    Long-Term Debt (variable interest entities restricted - 2025: $190; 2024: $—)

    17,849

    15,711

    Other Noncurrent Liabilities





    Deferred income tax liabilities

    364

    392

    Pension and other postretirement benefits - noncurrent

    4,694

    4,736

    Asbestos-related liabilities - noncurrent

    628

    713

    Operating lease liabilities - noncurrent

    1,097

    984

    Other noncurrent obligations

    7,201

    6,637

    Total other noncurrent liabilities (variable interest entities restricted - 2025: $364; 2024: $13)

    13,984

    13,462

    Stockholders' Equity





    Common stock (authorized 5,000,000,000 shares of $0.01 par value each;

    issued 2025: 790,287,565 shares; 2024: 784,471,939 shares)

    8

    8

    Additional paid-in capital

    11,112

    9,203

    Retained earnings

    16,781

    20,909

    Accumulated other comprehensive loss

    (7,660)

    (8,110)

    Treasury stock at cost (2025: 73,065,152 shares; 2024: 80,859,145 shares)

    (4,233)

    (4,655)

    Dow Inc.'s stockholders' equity

    16,008

    17,355

    Noncontrolling interests

    1,514

    496

    Total equity

    17,522

    17,851

    Total Liabilities and Equity

    $       58,538

    $       57,312

     

    Dow Inc. and Subsidiaries

    Consolidated Statements of Cash Flows



    In millions (Unaudited) For the years ended Dec 31,

    2025

    2024

    Operating Activities





    Net income

    $     (2,444)

    $       1,201

    Adjustments to reconcile net income to net cash provided by operating activities:





    Depreciation and amortization

    2,834

    2,894

    Provision (credit) for deferred income tax

    (341)

    135

    Earnings of nonconsolidated affiliates less than dividends received

    439

    348

    Net periodic pension benefit credit

    (95)

    (210)

    Pension contributions

    (209)

    (121)

    Net gain on sales of assets, businesses and investments

    (220)

    (65)

    Restructuring, goodwill impairment and asset related charges - net

    1,856

    103

    Other net loss

    440

    239

    Changes in assets and liabilities, net of effects of acquired and divested companies:





    Accounts and notes receivable

    73

    (224)

    Inventories

    (52)

    (529)

    Accounts payable

    (999)

    278

    Other assets and liabilities, net

    (220)

    (1,146)

    Cash provided by operating activities - continuing operations

    1,062

    2,903

    Cash provided by (used for) operating activities - discontinued operations

    (30)

    11

    Cash provided by operating activities

    1,032

    2,914

    Investing Activities





    Capital expenditures

    (2,479)

    (2,940)

    Proceeds from incentives related to capital expenditures

    145

    —

    Cash flow hedging related to capital expenditures

    (40)

    —

    Investment in gas field developments

    (157)

    (203)

    Proceeds from sales of property, businesses and consolidated companies, net of cash divested

    139

    234

    Acquisitions of property and businesses, net of cash acquired

    —

    (125)

    Investments in and loans to nonconsolidated affiliates

    (32)

    (28)

    Proceeds from sales of ownership interests in nonconsolidated affiliates

    125

    —

    Purchases of investments

    (881)

    (1,809)

    Proceeds from sales and maturities of investments

    1,022

    2,536

    Other investing activities, net

    32

    (33)

    Cash used for investing activities

    (2,126)

    (2,368)

    Financing Activities





    Changes in short-term notes payable

    (5)

    (61)

    Proceeds from issuance of short-term debt greater than three months

    64

    143

    Payments on short-term debt greater than three months

    (63)

    (17)

    Proceeds from issuance of long-term debt

    2,778

    1,467

    Payments on long-term debt

    (1,461)

    (267)

    Collections on securitization programs, net of remittances

    (9)

    (9)

    Purchases of treasury stock

    —

    (494)

    Proceeds from issuance of stock

    85

    166

    Transaction financing, debt issuance and other costs

    (137)

    (14)

    Employee taxes paid for share-based payment arrangements

    (18)

    (39)

    Distributions to noncontrolling interests

    (173)

    (77)

    Proceeds from sale of noncontrolling interests

    2,943

    —

    Dividends paid to stockholders

    (1,490)

    (1,966)

    Other financing activities, net

    (6)

    —

    Cash provided by (used for) financing activities

    2,508

    (1,168)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    275

    (163)

    Summary





    Decrease in cash, cash equivalents and restricted cash

    1,689

    (785)

    Cash, cash equivalents and restricted cash at beginning of year

    2,263

    3,048

    Cash, cash equivalents and restricted cash at end of year

    $       3,952

    $       2,263

    Less: Restricted cash and cash equivalents, included in "Other current assets"

    136

    74

    Cash and cash equivalents at end of year

    $       3,816

    $       2,189

     

    Dow Inc. and Subsidiaries

    Net Sales by Segment and Geographic Region

     



    Net Sales by Segment

    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)

    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Packaging & Specialty Plastics

    $    4,744

    $     5,315

    $   19,970

    $   21,776

    Industrial Intermediates & Infrastructure

    2,688

    2,948

    11,163

    11,869

    Performance Materials & Coatings

    1,852

    1,965

    8,134

    8,574

    Corporate

    176

    177

    701

    745

    Total

    $    9,460

    $   10,405

    $   39,968

    $   42,964

    U.S. & Canada

    $    3,677

    $     3,953

    $   15,806

    $   16,423

    EMEAI 1

    2,953

    3,334

    12,589

    13,958

    Asia Pacific

    1,786

    1,995

    7,219

    7,707

    Latin America

    1,044

    1,123

    4,354

    4,876

    Total

    $    9,460

    $   10,405

    $   39,968

    $   42,964

     

    Net Sales Variance by

    Segment and Geographic

    Region

    Three Months Ended Dec 31, 2025

    Twelve Months Ended Dec 31, 2025



    Local

    Price &

    Product

    Mix

    Currency

    Volume

    Portfolio /

    Other 2

    Total

    Local

    Price &

    Product

    Mix

    Currency

    Volume

    Portfolio /

    Other 2

    Total



    Percent change from prior year



    Packaging & Specialty

    Plastics

    (9) %

    1 %

    (2) %

    (1) %

    (11) %

    (8) %

    1 %

    — %

    (1) %

    (8) %



    Industrial Intermediates &

    Infrastructure

    (9)

    1

    (1)

    —

    (9)

    (6)

    —

    —

    —

    (6)



    Performance Materials &

    Coatings

    (4)

    —

    (2)

    —

    (6)

    (3)

    —

    (2)

    —

    (5)



    Total

    (8) %

    1 %

    (2) %

    — %

    (9) %

    (7) %

    — %

    — %

    — %

    (7) %



    Total, excluding the

    Hydrocarbons & Energy

    business

    (8) %

    1 %

    (1) %

    — %

    (8) %

    (6) %

    — %

    — %

    (1) %

    (7) %



    U.S. & Canada

    (7) %

    — %

    — %

    — %

    (7) %

    (6) %

    — %

    2 %

    — %

    (4) %



    EMEAI 1

    (9)

    4

    (5)

    (1)

    (11)

    (7)

    2

    (4)

    (1)

    (10)



    Asia Pacific

    (8)

    —

    (2)

    —

    (10)

    (7)

    —

    1

    —

    (6)



    Latin America

    (10)

    —

    3

    —

    (7)

    (8)

    —

    (2)

    (1)

    (11)



    Total

    (8) %

    1 %

    (2) %

    — %

    (9) %

    (7) %

    — %

    — %

    — %

    (7) %



     

    Net Sales Variance by Segment and Geographic Region

    Three Months Ended Dec 31, 2025



    Local

    Price &

    Product

    Mix

    Currency

    Volume

    Total



    Percent change from prior quarter



    Packaging & Specialty Plastics

    (4) %

    — %

    1 %

    (3) %



    Industrial Intermediates & Infrastructure

    (3)

    —

    (2)

    (5)



    Performance Materials & Coatings

    (2)

    —

    (9)

    (11)



    Total

    (3) %

    — %

    (2) %

    (5) %



    Total, excluding the Hydrocarbons & Energy business

    (3) %

    — %

    (3) %

    (6) %



    U.S. & Canada

    (2) %

    — %

    (4) %

    (6) %



    EMEAI 1

    (4)

    —

    —

    (4)



    Asia Pacific

    (3)

    (1)

    1

    (3)



    Latin America

    (4)

    —

    (4)

    (8)



    Total

    (3) %

    — %

    (2) %

    (5) %



    1. Europe, Middle East, Africa, and India.
    2. Portfolio & Other includes the sales impact of the flexible packaging laminating adhesives business, which was sold to Arkema S.A. in the fourth quarter of 2024.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures





    Operating EBIT by Segment



    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)



    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Packaging & Specialty Plastics



    $       215

    $       447

    $       827

    $    2,373

    Industrial Intermediates & Infrastructure



    (201)

    84

    (561)

    125

    Performance Materials & Coatings



    25

    (9)

    306

    318

    Corporate



    (6)

    (68)

    (150)

    (228)

    Total



    $         33

    $       454

    $       422

    $    2,588













    Depreciation and Amortization by Segment



    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)



    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Packaging & Specialty Plastics



    $       361

    $       385

    $    1,439

    $    1,483

    Industrial Intermediates & Infrastructure



    165

    156

    622

    599

    Performance Materials & Coatings



    174

    198

    740

    776

    Corporate



    8

    12

    33

    36

    Total



    $       708

    $       751

    $    2,834

    $    2,894













    Operating EBITDA by Segment



    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)



    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Packaging & Specialty Plastics



    $       576

    $       832

    $    2,266

    $    3,856

    Industrial Intermediates & Infrastructure



    (36)

    240

    61

    724

    Performance Materials & Coatings



    199

    189

    1,046

    1,094

    Corporate



    2

    (56)

    (117)

    (192)

    Total



    $       741

    $    1,205

    $    3,256

    $    5,482













    Equity in Earnings (Losses) of Nonconsolidated

    Affiliates by Segment



    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)



    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Packaging & Specialty Plastics



    $         (5)

    $        (15)

    $         35

    $         81

    Industrial Intermediates & Infrastructure



    (117)

    (39)

    (282)

    (102)

    Performance Materials & Coatings



    3

    2

    5

    11

    Corporate



    1

    1

    2

    4

    Total



    $      (118)

    $        (51)

    $      (240)

    $         (6)













    Reconciliation of "Net Income (Loss)" to "Operating

    EBIT"

    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)

    Sep 30,

    2025

    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Net income (loss)

    $       124

    $   (1,477)

    $        (35)

    $   (2,444)

    $    1,201

    + Provision (credit) for income taxes

    (54)

    (71)

    254

    (67)

    399

    Income (loss) before income taxes

    $         70

    $   (1,548)

    $       219

    $   (2,511)

    $    1,600

    -  Interest income

    47

    38

    57

    152

    200

    + Interest expense and amortization of debt discount

    221

    219

    216

    865

    811

    -  Significant items

    64

    (1,400)

    (76)

    (2,220)

    (377)

    Operating EBIT (non-GAAP)

    $       180

    $         33

    $       454

    $       422

    $    2,588

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures



    Significant Items Impacting Results for the Three Months Ended Dec 31, 2025

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $  (1,548)

    $  (1,543)

    $    (2.15)



    Less: Significant items









    2025 Restructuring Program severance and

    related benefit costs and asset related

    charges 4

    (41)

    (33)

    (0.05)

    Restructuring, goodwill impairment and asset

    related charges - net

    Implementation costs 5

    (43)

    (34)

    (0.05)

    Cost of sales ($44 million) offset by SG&A 

    ($1 million)

    Goodwill impairment 6

    (690)

    (671)

    (0.93)

    Restructuring, goodwill impairment and asset

    related charges - net

    Asset related charges 7

    (303)

    (303)

    (0.42)

    Restructuring, goodwill impairment and asset

    related charges - net

    Pension settlement charges 8

    (323)

    (257)

    (0.36)

    Sundry income (expense) - net

    Total significant items

    $  (1,400)

    $  (1,298)

    $    (1.81)



    Operating results (non-GAAP)

    $     (148)

    $     (245)

    $    (0.34)



     

    Significant Items Impacting Results for the Three Months Ended Dec 31, 2024

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $       219

    $       (53)

    $    (0.08)



    Less: Significant items









    Restructuring, implementation and efficiency

      costs, and asset related charges - net 4

    (89)

    (68)

    (0.10)

    Cost of sales ($60 million); R&D ($1 million);

      SG&A ($12 million); Restructuring and asset

      related charges - net ($34 million); offset by

      Sundry income (expense) - net ($18 million)

    Indemnifications and other transaction related

      costs 9

    13

    13

    0.02

    Sundry income (expense) - net

    Total significant items

    $        (76)

    $        (55)

    $     (0.08)



    Operating results (non-GAAP)

    $       295

    $           2

    $      0.00



    1. "Income (loss) before income taxes."
    2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
    3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
    4. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-manufacturing facilities, exit and disposal costs and other miscellaneous assets associated with the Company's 2025 Restructuring Program.
    5. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's formerly wholly owned subsidiary, Dow InfraCo, LLC.
    6. Related to a pretax impairment charge related to goodwill associated with the Polyurethanes & Construction Chemicals reporting unit.
    7. Related to a pretax impairment charge related to assets used for chlor-alkali, propylene oxide and brine production in Latin America.
    8. Non-cash settlement charges related to the termination of certain Company pension plans in the United States and United Kingdom.
    9. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures



    Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2025

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $  (2,511)

    $  (2,623)

    $    (3.70)



    Less: Significant items









    Restructuring, implementation and efficiency

      costs, and asset related charges - net 4

    (51)

    (39)

    (0.05)

    Cost of sales ($44 million); R&D ($1 million);

      SG&A ($4 million); Restructuring, goodwill

      impairment and asset related charges - net

      ($1 million); Sundry income (expense) - net

      ($1 million)

    2025 Restructuring Program severance and

      related benefit costs and asset related

      charges 5

    (862)

    (686)

    (0.97)

    Restructuring, goodwill impairment and asset

      related charges - net

    Implementation costs 6

    (53)

    (42)

    (0.07)

    Cost of sales ($49 million); SG&A ($4 million);

    Goodwill impairment  7

    (690)

    (671)

    (0.93)

    Restructuring, goodwill impairment and asset

      related charges - net

    Asset related charges 8

    (303)

    (303)

    (0.42)

    Restructuring, goodwill impairment and asset

      related charges - net

    Pension settlement charges 9

    (323)

    (257)

    (0.36)

    Sundry income (expense) - net

    Net gain on divestitures and asset sale 10

    213

    187

    0.26

    Sundry income (expense) - net

    Litigation related charges, awards and

      adjustments 11

    42

    33

    0.05

    Cost of sales

    Loss on early extinguishment of debt

    (78)

    (62)

    (0.09)

    Sundry income (expense) - net

    Indemnifications and other transaction related

      costs 12

    (115)

    (93)

    (0.13)

    Cost of sales ($98 million); Sundry income

      (expense) - net ($17 million)

    Income tax related items 13

    —

    (33)

    (0.05)

    Provision for income taxes

    Total significant items

    $  (2,220)

    $  (1,966)

    $    (2.76)



    Operating results (non-GAAP)

    $     (291)

    $     (657)

    $    (0.94)



    1. "Income (loss) before income taxes."
    2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
    3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
    4. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment in 2025 and impairment charges related to the write-down of certain manufacturing assets, partially offset by certain gains associated with  previously impaired equity investments in 2024.
    5. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-manufacturing facilities, exit and disposal costs and other miscellaneous assets associated with the Company's 2025 Restructuring Program.
    6. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's formerly wholly owned subsidiary, Dow InfraCo, LLC.
    7. Related to a pretax impairment charge related to goodwill associated with the Polyurethanes & Construction Chemicals reporting unit.
    8. Related to a pretax impairment charge related to assets used for chlor-alkali, propylene oxide and brine production in Latin America.
    9. Non-cash settlement charges related to the termination of certain Company pension plans in the United States and United Kingdom.
    10. Related to a gain on the sale of the soil fumigation product line and a gain on the sale of the Company's ownership interest in a nonconsolidated affiliate.
    11. Includes a gain associated with the reassessment of liabilities for certain accrued legacy agricultural products groundwater contamination matters, partially offset by the settlement of a separate claim related to water storage district legacy groundwater contamination matters.
    12. Primarily Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. Also includes charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
    13. Relates to valuation allowances on deferred tax assets in certain foreign jurisdictions, partially offset by a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner and a basis adjustment related to the consolidated infrastructure entity.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures



    Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2024

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $    1,600

    $    1,116

    $      1.57



    Less: Significant items









    Restructuring, implementation and efficiency

      costs, and asset related charges - net 4

    (315)

    (245)

    (0.35)

    Cost of sales ($184 million); R&D ($4 million);

      SG&A ($42 million); Restructuring and asset

      related charges - net ($103 million); offset by

      Sundry income (expense) - net ($18 million)

    Indemnifications and other transaction related

      costs 5

    (62)

    (45)

    (0.06)

    Cost of sales ($75 million); offset by Sundry

      income (expense) - net ($13 million)

    Income tax related items 6

    —

    194

    0.27

    Provision for income taxes

    Total significant items

    $      (377)

    $        (96)

    $     (0.14)



    Operating results (non-GAAP)

    $    1,977

    $    1,212

    $      1.71



    1. "Income (loss) before income taxes."
    2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
    3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
    4. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment in 2025 and impairment charges related to the write-down of certain manufacturing assets, partially offset by certain gains associated with  previously impaired equity investments in 2024.
    5. Includes a gain associated with the reassessment of liabilities for certain accrued legacy agricultural products groundwater contamination matters, partially offset by the settlement of a separate claim related to water storage district legacy groundwater contamination matters.
    6. Relates to reassessment of interest and penalties related to a tax matter in a foreign jurisdiction.

     

    Significant Items Impacting Results for the Three Months Ended Sep 30, 2025

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $          70

    $          62

    $       0.08



    Less: Significant items









    2025 Restructuring Program severance and

      related benefit costs and asset related

      charges 4

    (23)

    (18)

    (0.02)

    Restructuring and asset related charges -

      net

    Implementation costs 5

    (5)

    (4)

    (0.01)

    Cost of sales ($4 million); SG&A ($1 million)

    Net gain on divestitures and asset sale 6

    110

    110

    0.15

    Sundry income (expense) - net

    Loss on early extinguishment of debt

    (18)

    (14)

    (0.02)

    Sundry income (expense) - net

    Income tax related items 7

    —

    120

    0.17

    Provision for income taxes

    Total significant items

    $          64

    $        194

    $       0.27



    Operating results (non-GAAP)

    $            6

    $      (132)

    $     (0.19)



    1. "Income (loss) before income taxes."
    2. "Net income (loss) available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
    3. "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
    4. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities, exit and disposal costs and other miscellaneous assets associated with the Company's 2025 Restructuring Program.
    5. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's formerly wholly owned subsidiary, Dow InfraCo, LLC.
    6. Related to a gain on the sale of the Company's ownership interest in a nonconsolidated affiliate.
    7. Related to a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner and a basis adjustment related to the consolidated infrastructure entity.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures



    Reconciliation of Free Cash Flow

    Three Months Ended

    Twelve Months Ended

    In millions (Unaudited)

    Dec 31,

    2025

    Dec 31,

    2024

    Dec 31,

    2025

    Dec 31,

    2024

    Cash provided by operating activities - continuing operations (GAAP)

    $          298

    $          811

    $       1,062

    $       2,903

    Capital expenditures

    (568)

    (767)

    (2,479)

    (2,940)

    Free Cash Flow (non-GAAP)

    $         (270)

    $            44

    $     (1,417)

    $           (37)

     

    Reconciliation of Cash Flow Conversion

    Three Months Ended



    Mar 31,

    2025

    Jun 30,

    2025

    Sep 30,

    2025

    Dec 31,

    2025



    In millions (Unaudited)



    Cash provided by (used for) operating activities - continuing operations

      (GAAP)

    $       104

    $     (470)

    $    1,130

    $       298



    Net income (loss) (GAAP)

    $      (290)

    $     (801)

    $       124

    $   (1,477)



    Cash flow from operations to net income (GAAP) 1

    N/A

    N/A

    911.3 %

    N/A



    Cash flow from operations to net income - trailing twelve months (GAAP) 2



    N/A



    Operating EBITDA (non-GAAP)

    $       944

    $       703

    $       868

    $       741



    Cash Flow Conversion (Cash flow from operations to Operating EBITDA)

      (non-GAAP)

    11.0 %

    (66.9) %

    130.2 %

    40.2 %



    Cash Flow Conversion - trailing twelve months (non-GAAP)



    32.6 %



    1. Cash flow from operations to net income is not applicable for the first quarter of 2025, second quarter of 2025 and fourth quarter of 2025 due to a net loss for the period.
    2. Cash flow from operations to net income - trailing twelve months is not applicable due to a net loss for the trailing twelve months period.

     

    For further information, please contact:





    Investors:

    Andrew Riker

    [email protected]

    Media:

    Sarah Young

    [email protected]

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-fourth-quarter-2025-results-302673853.html

    SOURCE The Dow Chemical Company

    Get the next $DOW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOW

    DatePrice TargetRatingAnalyst
    8/14/2025$25.00Underperform → Neutral
    BofA Securities
    8/5/2025$40.00Neutral → Buy
    Rothschild & Co Redburn
    7/25/2025$32.00Outperform → In-line
    Evercore ISI
    6/23/2025$22.00Market Perform → Underperform
    BMO Capital Markets
    4/15/2025$28.00Buy → Underperform
    BofA Securities
    4/4/2025$31.00Overweight → Neutral
    Analyst
    1/7/2025$60.00 → $53.00Overweight → Neutral
    Piper Sandler
    12/18/2024$56.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $DOW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dow reports fourth quarter 2025 results

    MIDLAND, Mich., Jan. 29, 2026 /PRNewswire/ -- Dow (NYSE:DOW): FINANCIAL HIGHLIGHTS Net sales were $9.5 billion, down 9% year-over-year, reflecting declines in all operating segments. Sequentially, net sales were down 5%, led by local price and volume declines from normal seasonality.Volume decreased 2% year-over-year, led by declines in Packaging & Specialty Plastics, driven by lower merchant olefins sales in Europe, the Middle East, Africa and India (EMEAI) following the idling of a cracker in the region earlier in the year. Sequentially, volume decreased 2%, led by normal se

    1/29/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow launches Transform to Outperform to raise the competitive industry benchmark for productivity and growth to enable improved returns

    Targeting at least $2 billion near-term Op. EBITDA improvement Actions aim to radically simplify the Company's operating model, streamline its processes, reset its cost structure and modernize how it serves customers Benefits will be accretive to 2025 earnings levels and Dow's previously announced $1 billion cost savings programMIDLAND, Mich., Jan. 29, 2026 /PRNewswire/ -- Dow (NYSE:DOW) today announced a comprehensive plan to simplify how it operates and streamline its end-to-end processes. The Company will also reset its cost structure and modernize how it serves customers. Transform to Outperform targets the addition of at least $2 billion in near-term Op. EBITDA, in part by utilizing AI

    1/29/26 5:55:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Valtris Specialty Chemicals Announces New Chief Executive Officer

    Industry veteran Mike McGaugh appointed Valtris Specialty Chemicals ("Valtris"), a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Mike McGaugh as the company's new Chief Executive Officer. Mr. McGaugh has assumed the role held by former CEO, Simon Medley, who will be retiring as part of this transition but will continue to advise the company. Valtris is a portfolio company of SK Capital. "We are thrilled to welcome Mike, an industry veteran with a proven track record in the chemical and materials industries," said Jack Norris, a Managing Director of SK Capital. "Mike's decades of demonstrated leadership experience and

    1/13/26 6:30:00 AM ET
    $DOW
    $MYE
    Major Chemicals
    Industrials
    Plastic Products

    $DOW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dial Debra L. bought $26,197 worth of shares (675 units at $38.81) (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    2/11/25 4:15:26 PM ET
    $DOW
    Major Chemicals
    Industrials

    Director Banister Gaurdie E. Jr. bought $299,932 worth of shares (7,339 units at $40.87) (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    12/17/24 4:59:47 PM ET
    $DOW
    Major Chemicals
    Industrials

    Chair and CEO Fitterling James R bought $1,062,155 worth of shares (25,600 units at $41.49), increasing direct ownership by 11% to 117,837 units (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    12/16/24 4:19:06 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Argenton Andre claimed ownership of 48,687 shares (SEC Form 3)

    3 - DOW INC. (0001751788) (Issuer)

    1/9/26 4:06:56 PM ET
    $DOW
    Major Chemicals
    Industrials

    Senior Vice President Sampson John Maurice returned $7,704 worth of shares to the company (323 units at $23.85), decreasing direct ownership by 0.27% to 117,334 units (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    12/2/25 5:46:21 PM ET
    $DOW
    Major Chemicals
    Industrials

    Senior Vice President / CTO Sreeram Attiganal N returned $9,707 worth of shares to the company (407 units at $23.85), decreasing direct ownership by 0.31% to 129,791 units (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    12/2/25 5:46:12 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    SEC Filings

    View All

    Dow Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DOW INC. (0001751788) (Filer)

    1/29/26 6:09:25 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Other Events

    8-K - DOW INC. (0001751788) (Filer)

    1/29/26 6:02:07 AM ET
    $DOW
    Major Chemicals
    Industrials

    SEC Form 8-K filed by Dow Inc.

    8-K - DOW INC. (0001751788) (Filer)

    1/5/26 4:16:04 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dow upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dow from Underperform to Neutral and set a new price target of $25.00

    8/14/25 8:05:45 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow upgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn upgraded Dow from Neutral to Buy and set a new price target of $40.00

    8/5/25 7:03:19 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Dow from Outperform to In-line and set a new price target of $32.00

    7/25/25 8:58:32 AM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Leadership Updates

    Live Leadership Updates

    View All

    Valtris Specialty Chemicals Announces New Chief Executive Officer

    Industry veteran Mike McGaugh appointed Valtris Specialty Chemicals ("Valtris"), a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Mike McGaugh as the company's new Chief Executive Officer. Mr. McGaugh has assumed the role held by former CEO, Simon Medley, who will be retiring as part of this transition but will continue to advise the company. Valtris is a portfolio company of SK Capital. "We are thrilled to welcome Mike, an industry veteran with a proven track record in the chemical and materials industries," said Jack Norris, a Managing Director of SK Capital. "Mike's decades of demonstrated leadership experience and

    1/13/26 6:30:00 AM ET
    $DOW
    $MYE
    Major Chemicals
    Industrials
    Plastic Products

    Dow announces results from 2025 Annual Stockholder Meeting

    Declares quarterly dividend of 70 cents per shareRichard K. Davis re-elected independent lead directorMIDLAND, Mich., April 10, 2025 /PRNewswire/ -- Dow (NYSE:DOW) is pleased to report the results of its 2025 Annual Meeting of Stockholders. Today stockholders elected Samuel R. Allen, Gaurdie E. Banister Jr., Wesley G. Bush, Richard K. Davis, Jerri DeVard, Debra L. Dial, Jeff M. Fettig, Jim Fitterling, Jacqueline C. Hinman, Rebecca B. Liebert, Luis Alberto Moreno, Jill S. Wyant, and Daniel W. Yohannes to the Company's Board of Directors for one-year terms. Stockholders approved

    4/10/25 4:15:00 PM ET
    $DOW
    Major Chemicals
    Industrials

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    $DOW
    Financials

    Live finance-specific insights

    View All

    Dow reports fourth quarter 2025 results

    MIDLAND, Mich., Jan. 29, 2026 /PRNewswire/ -- Dow (NYSE:DOW): FINANCIAL HIGHLIGHTS Net sales were $9.5 billion, down 9% year-over-year, reflecting declines in all operating segments. Sequentially, net sales were down 5%, led by local price and volume declines from normal seasonality.Volume decreased 2% year-over-year, led by declines in Packaging & Specialty Plastics, driven by lower merchant olefins sales in Europe, the Middle East, Africa and India (EMEAI) following the idling of a cracker in the region earlier in the year. Sequentially, volume decreased 2%, led by normal se

    1/29/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow reports third quarter 2025 results

    MIDLAND, Mich., Oct. 23, 2025 /PRNewswire/ -- Dow (NYSE:DOW):  3Q25 FINANCIAL HIGHLIGHTS Net sales were $10.0 billion, down 8% year-over-year, reflecting declines in all operating segments. Sequentially, net sales were down 1%, as gains in Industrial Intermediates & Infrastructure were more than offset by declines in Packaging & Specialty Plastics and Performance Materials & Coatings.Volume decreased 1% year-over-year, as declines in Europe, the Middle East, Africa and India (EMEAI) were partly offset by gains in the U.S. and Canada and Asia Pacific. Sequentially, volume incre

    10/23/25 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow declares quarterly dividend of 35 cents per share

    MIDLAND, Mich., Oct. 9, 2025 /PRNewswire/ -- Dow (NYSE:DOW) has declared a dividend of 35 cents per share, payable December 12, 2025, to shareholders of record on November 28, 2025. This marks the 457th consecutive dividend paid by the Company or its affiliates since 1912. About DowDow (NYSE:DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, focused innovation, leading business positions and commitment to

    10/9/25 4:15:00 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Dow Inc.

    SC 13G/A - DOW INC. (0001751788) (Subject)

    11/12/24 2:25:16 PM ET
    $DOW
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Dow Inc.

    SC 13G/A - DOW INC. (0001751788) (Subject)

    11/4/24 11:51:32 AM ET
    $DOW
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Dow Inc.

    SC 13G/A - DOW INC. (0001751788) (Subject)

    10/17/24 12:57:12 PM ET
    $DOW
    Major Chemicals
    Industrials